Search research articles
Contact Us
Filters
Showing results (471-480 of 791) with videos related to
Page
of 80
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS)
Ajay K Kakkar, Mark N Levine, Zbigniew Kadziola, et al.
International Journal of Cancer
|
July 11, 2006
COX-2 upregulation in thymomas and thymic carcinomas
Ralf J Rieker, Stefan Joos, Gunhild Mechtersheimer, et al.
Langenbeck'S Archives of Surgery
|
March 11, 2016
Rescue management of early complications after liver transplantation-key for the long-term success
Joachim Andrassy, Sebastian Wolf, Verena Hoffmann, et al.
Transplantation
|
August 8, 2018
Effect of Donor Age on Outcome of Lung Transplantation Stratified by Recipient Diagnosis: A Nordic Multicenter Study
Henrik Auråen, Michael Thomas Durheim, Göran Dellgren, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 16, 2023
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan
Thomas Muley, Mark A Schneider, Michael Meister, et al.
Plos One
|
December 14, 2023
Invasively measured and estimated central blood pressure using the oscillometric algorithm Antares in patients with and without obesity
Alexander Stäuber, Marcus Dörr, Cornelia Piper, et al.
Cancer Letters
|
August 22, 2006
Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas
Michael Meister, Peter Schirmacher, Hendrik Dienemann, et al.
Medical Oncology (Northwood, London, England)
|
June 16, 2018
ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer
Matthias Villalobos, Piotr Czapiewski, Niels Reinmuth, et al.
Oncology Letters
|
June 13, 2019
Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab
Matthias Villalobos, Piotr Czapiewski, Niels Reinmuth, et al.
International Journal of Oncology
|
August 3, 2007
Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells
Niels Reinmuth, Sonja Rensinghoff, Miriam Raedel, et al.
Page
of 80
Search research articles
Search
Showing results (471-480 of 791) with videos related to
Sort By:
Page
of 80
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2004
Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS)
Ajay K Kakkar, Mark N Levine, Zbigniew Kadziola, et al.
International Journal of Cancer
|
July 11, 2006
COX-2 upregulation in thymomas and thymic carcinomas
Ralf J Rieker, Stefan Joos, Gunhild Mechtersheimer, et al.
Langenbeck'S Archives of Surgery
|
March 11, 2016
Rescue management of early complications after liver transplantation-key for the long-term success
Joachim Andrassy, Sebastian Wolf, Verena Hoffmann, et al.
Transplantation
|
August 8, 2018
Effect of Donor Age on Outcome of Lung Transplantation Stratified by Recipient Diagnosis: A Nordic Multicenter Study
Henrik Auråen, Michael Thomas Durheim, Göran Dellgren, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 16, 2023
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan
Thomas Muley, Mark A Schneider, Michael Meister, et al.
Plos One
|
December 14, 2023
Invasively measured and estimated central blood pressure using the oscillometric algorithm Antares in patients with and without obesity
Alexander Stäuber, Marcus Dörr, Cornelia Piper, et al.
Cancer Letters
|
August 22, 2006
Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas
Michael Meister, Peter Schirmacher, Hendrik Dienemann, et al.
Medical Oncology (Northwood, London, England)
|
June 16, 2018
ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer
Matthias Villalobos, Piotr Czapiewski, Niels Reinmuth, et al.
Oncology Letters
|
June 13, 2019
Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab
Matthias Villalobos, Piotr Czapiewski, Niels Reinmuth, et al.
International Journal of Oncology
|
August 3, 2007
Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells
Niels Reinmuth, Sonja Rensinghoff, Miriam Raedel, et al.
Page
of 80